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ABSTRACT 
Aim: There are many antibiotics used in acute 
sinusitis in paediatric practice. We planned this study 
to contribute rational antibacterial treatment 
considering the clinical efficiency, side effects and 
cost of the treatment. 
Materials and methods: Our study was a 
prospective, randomized and open label study in 
children . Patients diagnosed as having acute sinusitis 
based on the major and minor clinical diagnostic 
criteria were randomized to receive 14 days of 
amoxicillin (40 mg/kg/day, in 3 doses), 5 days of 
azithromycin (10 mg/kg/day, single dose for first 3 
days and 5 mg/kg/day-single dose for 2 days) and 14 
days of cefprozil (30 mg/kg/day, 2 doses) . 
Results: Of a total of 151 patients who were 
between the ages of5 and 14 years (mean: 8.33±2.82 
standard error), 50 patients received amoxicillin, 52 
azitromycin and 49 cefprozil. At the end of the 
treatment improvement rates were 72 %,80.7 %, and 
69.3 % respectively (p>0.05). The occurrence rates 
of adverse effects were 8 %, 7 %, and 10 % in these 
groups respectively (p > 0.05) . 
Conclusion: We emphasize that clinicians should 
prefer appropriate antibiotics for acute sinusitis in 
children, in regard to the parameters of low cost, high 
compliance and minimum adverse effects . 
Key words: amoxicillin, azithromycin, cefprozil , 
children, sinusitis, treatment 
INTRODUCTION 
Acute sinusitis is a common disease that millions 
of people suffer from in the world. In United States of 
America 3 million people are diagnosed with sinusitis 
in a year. This is the fifth leading cause of outpatient 
infectious disease. Inaccurate or misdiagnosis of 
sinusitis leads to many problems in the course of the 
disease. Resolution of symptoms is delayed, and 
insufficient antibiotic use may cause chronic sinusitis. 
In some conditions serious bacterial complications 
may occur. On the other hand, antibiotic abuse may 
increase the treatment cost, side effects, and bacterial 
resistance. So it is important to determine the cost-
effective treatment strategies (1). 
JUNE 2004 9 
Werninget al conducted a study in which internal 
medicine specialists' , otorhinolaryngologists', and 
family practitioners' suggestions for acute sinusitis 
treatment were examined. In that study 
otorhinolaryngologists were using more imaging 
techniques, more drugs than internal medicine 
specialists and family practitioners (2). Considering 
that otorhinolaryngologists deal with recurrences and 
complications more frequently the above mentioned 
difference can be explanied. 
Ultrasonography, computerized tomography, 
magnetic resonance imaging, anterior rhinoscopy, 
antral punction and nasal cytology were not included 
in the study. Because they are expensive, invasive, 
needs more time and expertise for the first step of 
health services, it seems that it is not possible to use 
them in routine practice (1). 
In the literature we could not find a comparative 
study of amoxicillin, azitromycin and cefprozil in 
childhood sinusitis. When the diagnosis is accurate in 
childhood sinusitis antibiotic treatment is needed. 
Kakish et al conducted a study in 249 acute sinusitis 
patients. They gave antibiotics to 88% of them and did 
not give any antibiotics to 12% of them. Amoxicillin 
was the drug of choice in 35.8% of those given 
antibiotics; 23% azithromycine, 15% cefaclor, 10% 
TMP-SMX, 8.5% amoxicillin-clavulanic acid, 3.5% 
ampicillin, 3.5% clarithromycin were the others. At 
the end of the study on the 10th day they controlled 
the patients and found a significant difference between 
the treated and untreated group. The treatment group 
improved (3) . According to the clinical literature 
data , in acute sinusitis judicious antibiotic treatment 
is needed in order to prevent the development of 
complications and chronicity (1). 
Nasal cytology does not give any information 
about the intrasinusoidal bacteriology (4). Anterior 
Table-l Major and minor criteria for diagnosing 
acute sinusitis 
Major criteria 
Pressure or pain on face/head 
Sensation of fullness on face 
Nasal congestion 
Nasal discharge 
Hyposmia/ anosmia 
Fever 
Minor criteria 
Headache 
Halitosis 
Fatigue 
Toothache 
Cough 
Earache 
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rhinoscopy needs exact patient 
compliance and for children this 
is very difficult. Antral puncture is 
accepted as the gold standard in 
literature but it takes long time, is 
invasive and painful. 
Antibiotic prescription for 
acute sinusitis in outpatient 
practice, can have a major impact 
on cure and costs. We performed 
a prospective open label study to 
compare effectiveness of the three 
antibiotics in the treatment and 
cost of acute sinusitis in childhood. 
MATERIALS AND METHODS 
Our study was a prospective, 
randomized and open label study 
in children. Patients diagnosed as 
having acute sinusitis based on 
the major and minor clinical 
diagnostic criteria were 
randomized to receive 14 days of 
amoxicillin (40 mg/kg/day, in 3 
doses), 5 days of azithromycin 
(10 mg/kg/day, single dose for 
first 3 days and 5 mg/kg/day-
single dose for 2 days) and 14 
days of cefprozil (30 mg/kg/day, 
2 doses). 
All the patients included in the 
study were evaluated by the same 
doctor (DB). Children having any 
other disease were not included 
in the study. History of drug 
hypersensitivity and/or allergy, 
any antibiotic use fifteen days 
before the admission , mal-
ignancy, serious heart, liver, 
kidney or gastrointestinal disease 
were also criteria for non-
inclusion . 
Diagnosis of acute sinusitis 
was made by history and clinical 
findings. In Table-I, the major 
and minor criteria used for the 
diagnosis of acute sinusitis were 
given (4). According to these, 
patients having at least two major, 
or one major and two minor criteria 
were accepted as acute sinusitis 
(2) . (Tables 2,3). 
Treatment effectiveness of the 
three antibiotics were evaluated 
according to the improvement in 
clinical findings and complaints. 
(Tables 4, 5). 
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Table-2 Distribution of the study groups according to complaints at 
admission* 
I. Group 11. Group III.Group 
(Amoxicillin) (Azithromicin) (Cefprozil) 
(n:SO) (n:S2) (n:49) 
Fever 41(%82) 52(%100) 49(%100) p<0.05 
Cough 26(%52) 44(%84.6) 36(%73.5) p<0.05 
Headache 39(%78) 26(%50) 36(%73.5) p<0.05 
Nasal discharge 27 (%54) 30 (%57.7) 28 (%57.4) p>0.05 
Congestion 22 (% 44) 15 (%28.8) 13 (%26.5) p>0.05 
Halitosis 10(% 20) 3(%5.8) 10(%20.4) p>0.05 
*percentages are to be evaluated for the same group 
In our study the most common complaints were fever, cough and 
headache (Table 2). 
Table-3 Distribution of the study groups according to physical ex-
amination findings at admission * 
I. Group I1.Group Ill. Group 
(Amoxicillin) (Azithromicin) (Cefprozil) 
Postnasal drainage 
Fever 
Nasal discharge 
Halitosis 
(n:SO) (n:S2) (n:49) 
50(%100) 
39(%78) 
27(%54) 
11(%22) 
52(%100) 
52(%100) 
16(%30.8) 
4(%7.7) 
49(%100) 
49(%100) 
25(%51) 
7(%14.3) 
*percentages are to be evaluated for the same group 
p>0.05 
p<0.05 
p<0.05 
p>0.05 
The most common physical examination findings at the admission were 
postnasaldrainage and fever. (Table 3). 
Table-4 Distribution of the study groups according to complaints and 
physical examination findings at control * 
I. Group n.Group III.Group 
(Amoxicillin) (Azithromicin) (Cefprozil) 
(n:SO) (n:S2) (n:49) 
Fever %0 %2 %6 p>0.05 
Cough %43 %20 %34 p>0.05 
Headache %25 %42 %26 p>0.05 
Nasal discharge %37 %52 %47 p>0.05 
Nasal congestion %46 %42 %59 p >0.05 
Halitosis %18 %0 %0 p>0.05 
Postnasal drainage %36 %31 %41 p>0.05 
*percentages are to be evaluated for the same group 
When we compare the complaints and physical examination finding 
before and after treatment, there were no statistically significant differences 
between the groups (p> 0.05). The most persistent finding was nasal 
congestion in all three groups. 
1) "Cure" was defined by 
disappearance of the two 
major, or one major and two 
minor criteria 
2) "Partial clinical improvement" 
was defined by disappearance 
of one major criteria and/ or 
any minor criteria. 
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3) "Failure" was defined by persistence of one major 
criterion. The failure group was sent to the 
Outpatient Unit of the Ear-Nose-Throat section. 
Patients were asked for the adverse effects in the 
control examination. (Table 5) . 
The statistical analysis of this study was done by 
SPSS 10.0. P values less than 0.05 were accepted as 
significant. 
In the evaluation of the parameters, Student's T 
test, Chi square and Correlation test was used. The 
data was given as mean and standard deviation. 
RESULTS 
A total of 151 patients who were between the ages 
of 5 and 14 years were included in the study (mean: 
8.33±2.82 standard error). In our study 50 of 151 
patients received amoxicillin, 52 azithromycin and 
49 cefprozil. At the end ofthe treatment improvement 
rates were 72 %, 80.7 %, and 69.3 % respectively 
(p>0.05). (Table 6). The occurrence rates of adverse 
effects were 8 %, 7 %, and 10 % in these groups 
respectively (p> 0 .05). (Table 5) . 
DISCUSSION 
Acute sinusitis is a very common infection in 
childhood, but its management remains a controversial 
issue. Cefprozil and azithromicin are acceptable 
alternatives to amoxicillin in the treatment of sinusitis 
in children. As stated before, because of the risk of 
complications and chronicity this study was not 
designed as placebo controlled. History and physical 
examination was used for diagnosis. Waters' 
radiological view and leukocyte count was important 
for supporting the clinical diagnosis. Ros et al. 
compared the Waters' view with three dimensional 
head views and found that Waters' view is sufficient 
with a sensitivity of 89% and a specifity of 83% in 
diagnosing acute sinusitis (5). Sowe used the Waters' 
view not as a diagnostic tool it to but to evaluate the 
relationship with the clinical diagnosis. 
Engels et al made a meta-analysis in which 6 
studies for the diagnosis of acute sinusitis were 
included. In one part of the meta analysis sinus 
aspiration ad sinus radiographs were compared. When 
the positivity of X-rays was defined as the presence of 
fluid in the sinus and/or opacity and/or mucosal 
thickening they found out the sensitivity asO.9 and 
specificity as 0 .61 (1). Stewart et al states that in 
primary care, the physician does not need imaging 
techniques for diagnosing uncomplicated acute 
sinusitis (7). In our study there were correlation 
between Waters' view improvement and general 
clinical outcome. We have the results which are 
parallel with the studies suggesting that every imaging 
technique needs to be evaluated under the light of 
history and clinical examination (1, 4, and 5). 
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Table-5 Distribution of the study groups according 
to adverse effects 
I. Group II.Group Ill.Group 
(Amoxicillin) (Azithromicin) (Cefprozil) 
(n:50) (n:52) (n:49) 
Abdominal pain 2 1 
3 
o 
1 
4 
o 
Nausea 1 
Constipation 1 
Total %8 %7 %10 
Table-6 Distribution of the study groups according 
to the clinical improvement 
Clinical 
improvement 
Failure 
I. Group II.Group IIl.Group 
(Amoxicillin) (Azithromicin) (Cefprozil) 
(n:50) (n:52) (n:49) 
36(%72) 
14(%28) 
42(%80.7) 34(%69.3) 
10(%19.3) 15(%30.7) 
p>0.05 
In our study the most common complaints were 
fever, cough and headache. Families tend to bring 
their child when he/she has fever otherwise they wait 
for recovery. Night cough especially alarms the family. 
The mean age (8.33 year) of our study group was 
appropriate for expressing their complaints by 
themselves. 
Williams et al. asked for symptoms of acute sinusitis 
in a prospective study of 221 adult patients and found 
out that the most common complaint was fatigue 
(62%) (8). In our study the most common complaint 
was fever (95%). Fatigue probably couldn't be 
expressed by our patients because they are in the 
childhood age group. Lindbaeck et al. found out that 
in 357 adult patients clinical diagnosis of sinusitis is 
generally correct and erythrocyte sedimentation rate, 
C reactive protein and leukocyte count has a limited 
value in diagnosis of sinusitis. We also found 
leukocytosis only in 33.8% of the patients (9). Conrad 
et al. published a review and determined that childhood 
sinusitis is caused by S. pneumonia , H. influenza and 
M. catarrhalis, radiologic examination is unnecessary 
and the first treatment regimen should be high dose 
amoxicillin (80-90 mg/kg/day) at least 7 days after 
the symptom resolution; approximately 10-14 days 
(10). We used the 14 day standard treatment regimen 
for amoxicillin since our study population is of a lower 
socio-economic status. 
In a study conducted by Virant, 30-50% of childhood 
sinusitis patients also have asthma. In these patients 
aggressive medical or surgical treatments enable 
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relief of both upper and lower respiratory symptoms 
in a significant manner. Judicious antibiotic use is 
also useful for relieving asthma symptoms in these 
patients (11). 
Garbut et al. conducted a comparative study for 
amoxicillin, amoxicillin-clavulanate, and placebo; and 
found out no statistically significant difference in 
treatment effectiveness. This information may make 
us think that in childhood sinusitis there is no need for 
antibiotics, but the investigators, used S5 score 
(congestion, day cough, head or facial pain, colored 
nasal ml}cus) (12). They wanted from the parents to 
score those parameters 0-3. This seems to be a 
subjective scaling, because parents may exaggerate 
or minimize the symptoms according to their 
personality. Williams et al published an article in 
which 32 studies about adult acute maxillary sinusitis 
were included. They stated that although recent 
evidence has been limited, 7 -14 days of penicillin or 
amoxicillin treatment is useful. Additionally they 
recommended that the balance between the treatment 
benefit and the adverse effects should be evaluated 
before prescribing the antibiotic (13). In our study, 
because we found no statistically significant difference 
between effectiveness and adverse effects, we may 
conclude that all the three drugs may be prescribed 
confidently with respect to this balance. From the 
three drugs, azithromycin had not only the highest 
percentage of treatment effectiveness, but also the 
lowest percentage of adverse effects. 
In a meta - analysis (11 studies and 1742 patients), 
loannidis et al studied azithromycin in sinusitis 
treatment, and found that there were no statistically 
significant difference between azithromycin and other 
antibiotics in respect to treatment effectiveness. In 
that meta- analysis, there were 0.8 % drop outs 
because of the adverse effects (14) . [n our study we 
also didn't find any significant difference between 
treatment effectiveness of azithromycin and the other 
drugs, but we had no drop outs because of the adverse 
effects. 
Garcia et al conducted a study in which 78 adult 
and paediatric patients having acute respiratory 
system infection were compared for the treatment 
effectiveness of azithromycin, amoxicillin- clavulanate 
and cefaclor. They found 97% of azithromycin patients 
were improved or cured, 85 % of amoxicillin-
clavulanate and 84% of cefaclor group accordingly. 
Azithromycin had statistically significant difference 
in treatment effectiveness than amoxicilin-clavulonic 
acid and cefaclor (p< 0.02). Adverse effect frequency 
was 0%; 15%; and 16% accordingly (15). Although 
antibiotics and the indication of use are not the same, 
we also found azithromycin as the most efficient one 
with a percentage of 80.7; but this is not statistically 
significant. This difference may be caused by the 
difference between the indications of the antibiotic 
use (acute respiratory system infection vs. acute 
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sinusitis). The adverse effect ratios were similar in our 
study. Azithromycin had 7%, amoxicillin had 8%, and 
cefprozil had 10%. 
There are limited studies that investigate the 
treatment effectiveness of cefprozil in acute sinusitis. 
In a study conducted by Hedrich et ai, it has been 
shown that in acute otitis media, high dose amoxicillin-
clavulanate and cefprozil had equal treatment 
effectiveness and low adverse effect profile (16). 
Arguedas et ai, showed similar results in otitis 
media with effusion, i.e. that cefprozil has an effect 
equal to amoxicillin-clavulanate, but a lower adverse 
effect profile (17). Adelglass et al conducted a study 
in 278 adult patients and compared amoxicillin-
clavulanate and cefprozil. They found no significant 
difference between the treatment effectiveness of the 
two, but adverse effect frequency is high for amoxicillin-
clavulanate (18). We conducted our study in a 
paediatric age group and found similar results for 
amoxicillin and cefprozil but cefprozil has more frequent 
adverse effects than amoxicillin (10% and 8%). 
Cassiano determined that short term amoxicillin 
use (10 days) is as effective as azithromycin use (5 
days) in adulthood acute maxillary sinusitis. Short 
term antibiotic use has advantages in terms of 
treatment compliance, adverse effect frequency and 
bacterial resistance (19) . Pichichero published a 
review and stated that short term antibiotic use has 
similar results with long term use in acute sinusitis 
(20). We also found out no significant difference 
between 5 days azithromycin, 14 days amoxicillin 
and 14 days cefprozil treatment. For childhood sinusitis 
there is a need for more short term studies. 
Brook et ai, in one of their reviews listed the 
indications for referral to an otorhinolaryngologist as 
treatment failure, immune deficiency, nosocomial 
infections and disturbance ofthe general status ofthe 
patients (4). In our study we referred the treatment 
failure group (25 .8%) to an otorhinolaryngologist. 
Powers, in his study comparing the taste of 
azithromycin with other antibiotics, concluded that 
dose interval, treatment duration and the taste of the 
drug affected the compliance and the clinical outcome. 
Children preferred azithromycin to cefpodoxime (90% 
to 52%); and tocefprozil (63%t033, 1 %). Azithromycin 
is an effective antibiotic, with its taste influencing the 
compliance and the clinical outcome (21). 
At the end of the study "clinical improvement" was 
evaluated as total (TI), partial (PI) or no improvement 
(N[) respectively. These figures for amoxicillin were 
62%, 10% and 28%, for azithromycin 64%, 17% and 
19% and for cefprozil53%, 17% and 30% respectively. 
When total and partial improvements were 
collectively defined as clinical improvement (C[), the 
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figures became 72% for amoxicillin , 81 % for 
azithromycine and 69% for cefprozil, the difference of 
which were not statistically significant. 
Adverse effect rates were 8% in the amoxicillin 
group, 7% in the azithromycine group and 10% in the 
cefprozil group. These were mild reactions and there 
was no need to stop the treatment in any patient. 
Piccirilo et al found out that first line and second 
line drugs have similar treatment effectiveness but 
second line drugs have a nearly two fold cost compared 
to first line drugs (22). 
In our country amoxicillin is the cheapest drug, 
and azithromycin has two fold and cefprozil has five 
fold cost. In the paediatric age group sinusitis is a very 
common disease. Therefore we emphasize that the 
preference of the cheapest and effective antibiotic is 
a more realistic and rational treatment policy . 
REFERENCES 
1) Engels EA, Terrin N, Barza M,Lau J . Meta-analysis 
of diagnostic tests for acute sinusitis. J Clin 
Epidemiol (53); 852-62,2000 
2) Werning JW, Preston TW, Khuder S. Physician 
speciality is associated with differences in the 
evaluation and management of acute bacterial 
rhinosinusitis. Arch Otolaryngol Head Neck Surg 
128(2): 123-30,2002 
3) Kakish KS, Mahafza T, Batleha A, Ekteish F, 
Daoud A. Clinical sinusitis in children attending 
primary care centers. Pediatr Infect Dis J 
(19): 1 071-4,2000 
4) Brook I, Gooch MW, Jenkins SG , Pichichero EM, 
Reiner SA, Sher L, Yamauchi T. Medical 
management of acute bacterial sinusitis-
Recommendations of a clinical advisory 
committee on pediatric and adult sinusitis . Ann 
Oto Rhinol Laryngol (109):2-20,2000 
5) Ros SP, Herman BE, Azar-Kia B. Acute sinusitis 
in children: Is the Water's view sufficient? Pediatr 
Radiol (25) :306-7,1995 
6) Shapiro GG, Furukawa CT, Pierson WE, et al . 
Blinded comparison of maxillary sinus 
radiography and ultrasonography for diagnosis 
of sinusitis. J Allergy Clin Immunol (77):59-
64,1986; 
7) Stewart MH, Siff JE, Cydulka RK. Evaluation of 
the patient with sore throat, earache, and sinusitis: 
an evidence based approach. Emerg Med Clin 
North Am (17):153-87,1999 
JUNE 2004 13 
8) Williams JW, Simel DL, Roberts L. Clinical 
evaluation for sinusitis: Making the diagnosis by 
history and physical exam. Ann Intern Med 
(117):705-10,1992 
9) Lindbaeck M, Hjortdahl P, Johnsen ULH. 
Diagnosing acute sinusitis. J Fam Pract (43) ;23-
7,1996 
10) Conrad DA, Jenson HB. Management of acute 
bacterial rhinosinusitis . Curr Opin Pediatr 
14(1 ):86-90,2002 
11) Virant FS. Sinusitis and pediatric asthma. Pediatric 
Annals (29):434-7, 2000 
12) Garbutt JM, Goldstein M, Gelman E, Shannon W. 
A randomized, placebo controlled trial of 
antimicrobial treatment for children with clinically 
diagnosed acute sinusitis. Pediatrics (107);619-
25,2001 
13) Williams JW Jr, Aguilar C, Makela M, Cornell J, 
Holleman DR, Chiquette E, Simel DL. Antibiotics 
for acute maxillary sinusitis. Cochrane Database 
Syst Rev, (2):CD000243,2000 
14) Loannidis JP, Contopoulos- loannidis DG, Chew 
P, Lau J. Meta-analysis ofrandomised controlled 
trials on the comperative efficacy and safety of 
azithromycin against other antibiotics for upper 
respiratory tract infections. J Antimicrob 
Chemother 48(5):677-89,2001 
15) Garcia Callejo FJ, Velert Vila MM, Orts Alborch 
MH, Pardo Mateu L, Esparcia Navarro M. 
Comparison of azithromycin, amoxcicillin/ 
clavulanic acid and cefaclor in the treatment of 
acute ENT infections. Acta Otorrhinolaryngol 
Esp; 49(4): 306-12,1998. 
16) Hedrick JA, Sher LD, Schwartz RH, Pierce P. 
Cefprozil versus high dose amoxicilin/clavulanate 
in children with acute otitis media. Clin Ther 
23(2) 193-204,2001 
17) Arguedas AG, Zaleska M, Stutman HR, Blumer 
JL, Hains CS. Comperative trial of cefprozil vs. 
amoxicilin clavulanate potassium in the treatment 
of children with acute otitis media with effusion. 
Pediatr Infect Dis J 10:375-80,1991 
18) Adelglass J, Bundy JM, Woods R. Clin Ther 
20(6):1115-29,1998 
19) Casiano RR. Azithromycin and amoxicilin in 
treatment of acute maxillary sinusitis. Am J 
Med.91(SuppI3A) :27-30,1991 
the family physician / it-tabib tal-familja 
20) Pichichero ME. Short course antibiotic therapy 
for respiratory infections: a review ofthe evidence. 
Pediatr Infect Dis J , (19):929-37,2000 
21) Powers JL. Properties of azithromycin that 
enhance the potential for compliance in children 
JUNE 2004 14 
with upper respiratory tract infections. Pediatr 
Infect Dis J 15(9 SuppJ):30-7,1996 
22) Piccirillo JF, Meger DE, Frisse ME, Brophy RH, 
Goggin A. Impact of first-line antibiotics for the 
treatment of acute uncomplicated sinusitis. JAMA 
20:287(11):1395-6,2002 
the family physician / it-tabib tal-familja 
"'1 
